Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

Deficiency of adenosine deaminase (ADA) causes a form of severe combined immunodeficiency disease. This study shows that gene therapy in the form of hematopoietic stem cells transduced with a viral vector containing the human ADA gene can restore immune function in patients with this disease. Defici...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2009-01, Vol.360 (5), p.447-458
Hauptverfasser: Aiuti, Alessandro, Cattaneo, Federica, Galimberti, Stefania, Benninghoff, Ulrike, Cassani, Barbara, Callegaro, Luciano, Scaramuzza, Samantha, Andolfi, Grazia, Mirolo, Massimiliano, Brigida, Immacolata, Tabucchi, Antonella, Carlucci, Filippo, Eibl, Martha, Aker, Memet, Slavin, Shimon, Al-Mousa, Hamoud, Al Ghonaium, Abdulaziz, Ferster, Alina, Duppenthaler, Andrea, Notarangelo, Luigi, Wintergerst, Uwe, Buckley, Rebecca H, Bregni, Marco, Marktel, Sarah, Valsecchi, Maria Grazia, Rossi, Paolo, Ciceri, Fabio, Miniero, Roberto, Bordignon, Claudio, Roncarolo, Maria-Grazia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 458
container_issue 5
container_start_page 447
container_title The New England journal of medicine
container_volume 360
creator Aiuti, Alessandro
Cattaneo, Federica
Galimberti, Stefania
Benninghoff, Ulrike
Cassani, Barbara
Callegaro, Luciano
Scaramuzza, Samantha
Andolfi, Grazia
Mirolo, Massimiliano
Brigida, Immacolata
Tabucchi, Antonella
Carlucci, Filippo
Eibl, Martha
Aker, Memet
Slavin, Shimon
Al-Mousa, Hamoud
Al Ghonaium, Abdulaziz
Ferster, Alina
Duppenthaler, Andrea
Notarangelo, Luigi
Wintergerst, Uwe
Buckley, Rebecca H
Bregni, Marco
Marktel, Sarah
Valsecchi, Maria Grazia
Rossi, Paolo
Ciceri, Fabio
Miniero, Roberto
Bordignon, Claudio
Roncarolo, Maria-Grazia
description Deficiency of adenosine deaminase (ADA) causes a form of severe combined immunodeficiency disease. This study shows that gene therapy in the form of hematopoietic stem cells transduced with a viral vector containing the human ADA gene can restore immune function in patients with this disease. Deficiency of adenosine deaminase causes a form of severe combined immunodeficiency disease. This study shows that gene therapy can restore immune function in patients with the disease. Adenosine deaminase (ADA) deficiency is a fatal autosomal recessive form of severe combined immunodeficiency (SCID), of which failure to thrive, impaired immune responses, and recurrent infections are characteristics. 1 , 2 Toxic levels of purine metabolites (adenosine and adenine deoxyribonucleotides) due to the deficiency of ADA can cause hepatic, skeletal, neurologic, and behavioral alterations 1 , 3 , 4 and sensorineural deafness. 5 A hematopoietic stem-cell transplant from an HLA-identical sibling, the treatment of choice, is available for only a minority of patients 6 – 8 ; the use of alternative donors is associated with a high risk of death or lack of engraftment. 1 , 6 Administration of polyethylene . . .
doi_str_mv 10.1056/NEJMoa0805817
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66865046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66865046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c548t-ecf80bddcbf9ce96fe2b23019c808f4779081dfd4a25864545aca96e27f6f8ad3</originalsourceid><addsrcrecordid>eNp10EFLwzAUB_AgipvTo1cpgt6qSZukyXFscypTL_NcsvQFO5ZkJuth396OVYeCubzw-PHe44_QJcF3BDN-_zp5fvEKC8wEKY5Qn7A8TynF_Bj1Mc5ESguZ99BZjEvcPkLlKeoRSdouoX00nYKDZP4BQa23ifEhebK2cb4CU-sanN4m4waSjU-GFTgf61aPQdnaqbj7fatzdGLUKsJFVwfo_WEyHz2ms7fp02g4SzWjYpOCNgIvqkovjNQguYFskeWYSC2wMLQoJBakMhVVGROcMsqUVpJDVhhuhKryAbrdz10H_9lA3JS2jhpWK-XAN7HkXHCGKW_h9R-49E1w7W1lluWS5FSyFqV7pIOPMYAp16G2KmxLgstdvOWveFt_1Q1tFhaqg-7ybMFNB1TUamWCcrqOPy4jBBdFIQ7O2lg6WNp_Fn4B-faNIg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223913495</pqid></control><display><type>article</type><title>Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Aiuti, Alessandro ; Cattaneo, Federica ; Galimberti, Stefania ; Benninghoff, Ulrike ; Cassani, Barbara ; Callegaro, Luciano ; Scaramuzza, Samantha ; Andolfi, Grazia ; Mirolo, Massimiliano ; Brigida, Immacolata ; Tabucchi, Antonella ; Carlucci, Filippo ; Eibl, Martha ; Aker, Memet ; Slavin, Shimon ; Al-Mousa, Hamoud ; Al Ghonaium, Abdulaziz ; Ferster, Alina ; Duppenthaler, Andrea ; Notarangelo, Luigi ; Wintergerst, Uwe ; Buckley, Rebecca H ; Bregni, Marco ; Marktel, Sarah ; Valsecchi, Maria Grazia ; Rossi, Paolo ; Ciceri, Fabio ; Miniero, Roberto ; Bordignon, Claudio ; Roncarolo, Maria-Grazia</creator><creatorcontrib>Aiuti, Alessandro ; Cattaneo, Federica ; Galimberti, Stefania ; Benninghoff, Ulrike ; Cassani, Barbara ; Callegaro, Luciano ; Scaramuzza, Samantha ; Andolfi, Grazia ; Mirolo, Massimiliano ; Brigida, Immacolata ; Tabucchi, Antonella ; Carlucci, Filippo ; Eibl, Martha ; Aker, Memet ; Slavin, Shimon ; Al-Mousa, Hamoud ; Al Ghonaium, Abdulaziz ; Ferster, Alina ; Duppenthaler, Andrea ; Notarangelo, Luigi ; Wintergerst, Uwe ; Buckley, Rebecca H ; Bregni, Marco ; Marktel, Sarah ; Valsecchi, Maria Grazia ; Rossi, Paolo ; Ciceri, Fabio ; Miniero, Roberto ; Bordignon, Claudio ; Roncarolo, Maria-Grazia</creatorcontrib><description>Deficiency of adenosine deaminase (ADA) causes a form of severe combined immunodeficiency disease. This study shows that gene therapy in the form of hematopoietic stem cells transduced with a viral vector containing the human ADA gene can restore immune function in patients with this disease. Deficiency of adenosine deaminase causes a form of severe combined immunodeficiency disease. This study shows that gene therapy can restore immune function in patients with the disease. Adenosine deaminase (ADA) deficiency is a fatal autosomal recessive form of severe combined immunodeficiency (SCID), of which failure to thrive, impaired immune responses, and recurrent infections are characteristics. 1 , 2 Toxic levels of purine metabolites (adenosine and adenine deoxyribonucleotides) due to the deficiency of ADA can cause hepatic, skeletal, neurologic, and behavioral alterations 1 , 3 , 4 and sensorineural deafness. 5 A hematopoietic stem-cell transplant from an HLA-identical sibling, the treatment of choice, is available for only a minority of patients 6 – 8 ; the use of alternative donors is associated with a high risk of death or lack of engraftment. 1 , 6 Administration of polyethylene . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa0805817</identifier><identifier>PMID: 19179314</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Waltham, MA: Massachusetts Medical Society</publisher><subject>Adenosine Deaminase - deficiency ; Adenosine Deaminase - genetics ; Antigens, CD34 - genetics ; Biological and medical sciences ; Bone marrow ; Bone Marrow Cells - immunology ; Child, Preschool ; Combined Modality Therapy ; Ethics ; Follow-Up Studies ; Gene therapy ; General aspects ; Genetic Therapy ; Genetic Vectors ; Hematopoietic Stem Cell Transplantation ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infant ; Kinases ; Ligands ; Lymphocyte Count ; Medical sciences ; Metabolites ; Patients ; Retroviridae ; Severe Combined Immunodeficiency - immunology ; Severe Combined Immunodeficiency - therapy ; Transduction, Genetic ; Transplantation Conditioning ; Transplants &amp; implants</subject><ispartof>The New England journal of medicine, 2009-01, Vol.360 (5), p.447-458</ispartof><rights>Copyright © 2009 Massachusetts Medical Society. All rights reserved.</rights><rights>2009 INIST-CNRS</rights><rights>2009 Massachusetts Medical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c548t-ecf80bddcbf9ce96fe2b23019c808f4779081dfd4a25864545aca96e27f6f8ad3</citedby><cites>FETCH-LOGICAL-c548t-ecf80bddcbf9ce96fe2b23019c808f4779081dfd4a25864545aca96e27f6f8ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa0805817$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa0805817$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21107778$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19179314$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aiuti, Alessandro</creatorcontrib><creatorcontrib>Cattaneo, Federica</creatorcontrib><creatorcontrib>Galimberti, Stefania</creatorcontrib><creatorcontrib>Benninghoff, Ulrike</creatorcontrib><creatorcontrib>Cassani, Barbara</creatorcontrib><creatorcontrib>Callegaro, Luciano</creatorcontrib><creatorcontrib>Scaramuzza, Samantha</creatorcontrib><creatorcontrib>Andolfi, Grazia</creatorcontrib><creatorcontrib>Mirolo, Massimiliano</creatorcontrib><creatorcontrib>Brigida, Immacolata</creatorcontrib><creatorcontrib>Tabucchi, Antonella</creatorcontrib><creatorcontrib>Carlucci, Filippo</creatorcontrib><creatorcontrib>Eibl, Martha</creatorcontrib><creatorcontrib>Aker, Memet</creatorcontrib><creatorcontrib>Slavin, Shimon</creatorcontrib><creatorcontrib>Al-Mousa, Hamoud</creatorcontrib><creatorcontrib>Al Ghonaium, Abdulaziz</creatorcontrib><creatorcontrib>Ferster, Alina</creatorcontrib><creatorcontrib>Duppenthaler, Andrea</creatorcontrib><creatorcontrib>Notarangelo, Luigi</creatorcontrib><creatorcontrib>Wintergerst, Uwe</creatorcontrib><creatorcontrib>Buckley, Rebecca H</creatorcontrib><creatorcontrib>Bregni, Marco</creatorcontrib><creatorcontrib>Marktel, Sarah</creatorcontrib><creatorcontrib>Valsecchi, Maria Grazia</creatorcontrib><creatorcontrib>Rossi, Paolo</creatorcontrib><creatorcontrib>Ciceri, Fabio</creatorcontrib><creatorcontrib>Miniero, Roberto</creatorcontrib><creatorcontrib>Bordignon, Claudio</creatorcontrib><creatorcontrib>Roncarolo, Maria-Grazia</creatorcontrib><title>Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Deficiency of adenosine deaminase (ADA) causes a form of severe combined immunodeficiency disease. This study shows that gene therapy in the form of hematopoietic stem cells transduced with a viral vector containing the human ADA gene can restore immune function in patients with this disease. Deficiency of adenosine deaminase causes a form of severe combined immunodeficiency disease. This study shows that gene therapy can restore immune function in patients with the disease. Adenosine deaminase (ADA) deficiency is a fatal autosomal recessive form of severe combined immunodeficiency (SCID), of which failure to thrive, impaired immune responses, and recurrent infections are characteristics. 1 , 2 Toxic levels of purine metabolites (adenosine and adenine deoxyribonucleotides) due to the deficiency of ADA can cause hepatic, skeletal, neurologic, and behavioral alterations 1 , 3 , 4 and sensorineural deafness. 5 A hematopoietic stem-cell transplant from an HLA-identical sibling, the treatment of choice, is available for only a minority of patients 6 – 8 ; the use of alternative donors is associated with a high risk of death or lack of engraftment. 1 , 6 Administration of polyethylene . . .</description><subject>Adenosine Deaminase - deficiency</subject><subject>Adenosine Deaminase - genetics</subject><subject>Antigens, CD34 - genetics</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Bone Marrow Cells - immunology</subject><subject>Child, Preschool</subject><subject>Combined Modality Therapy</subject><subject>Ethics</subject><subject>Follow-Up Studies</subject><subject>Gene therapy</subject><subject>General aspects</subject><subject>Genetic Therapy</subject><subject>Genetic Vectors</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infant</subject><subject>Kinases</subject><subject>Ligands</subject><subject>Lymphocyte Count</subject><subject>Medical sciences</subject><subject>Metabolites</subject><subject>Patients</subject><subject>Retroviridae</subject><subject>Severe Combined Immunodeficiency - immunology</subject><subject>Severe Combined Immunodeficiency - therapy</subject><subject>Transduction, Genetic</subject><subject>Transplantation Conditioning</subject><subject>Transplants &amp; implants</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10EFLwzAUB_AgipvTo1cpgt6qSZukyXFscypTL_NcsvQFO5ZkJuth396OVYeCubzw-PHe44_QJcF3BDN-_zp5fvEKC8wEKY5Qn7A8TynF_Bj1Mc5ESguZ99BZjEvcPkLlKeoRSdouoX00nYKDZP4BQa23ifEhebK2cb4CU-sanN4m4waSjU-GFTgf61aPQdnaqbj7fatzdGLUKsJFVwfo_WEyHz2ms7fp02g4SzWjYpOCNgIvqkovjNQguYFskeWYSC2wMLQoJBakMhVVGROcMsqUVpJDVhhuhKryAbrdz10H_9lA3JS2jhpWK-XAN7HkXHCGKW_h9R-49E1w7W1lluWS5FSyFqV7pIOPMYAp16G2KmxLgstdvOWveFt_1Q1tFhaqg-7ybMFNB1TUamWCcrqOPy4jBBdFIQ7O2lg6WNp_Fn4B-faNIg</recordid><startdate>20090129</startdate><enddate>20090129</enddate><creator>Aiuti, Alessandro</creator><creator>Cattaneo, Federica</creator><creator>Galimberti, Stefania</creator><creator>Benninghoff, Ulrike</creator><creator>Cassani, Barbara</creator><creator>Callegaro, Luciano</creator><creator>Scaramuzza, Samantha</creator><creator>Andolfi, Grazia</creator><creator>Mirolo, Massimiliano</creator><creator>Brigida, Immacolata</creator><creator>Tabucchi, Antonella</creator><creator>Carlucci, Filippo</creator><creator>Eibl, Martha</creator><creator>Aker, Memet</creator><creator>Slavin, Shimon</creator><creator>Al-Mousa, Hamoud</creator><creator>Al Ghonaium, Abdulaziz</creator><creator>Ferster, Alina</creator><creator>Duppenthaler, Andrea</creator><creator>Notarangelo, Luigi</creator><creator>Wintergerst, Uwe</creator><creator>Buckley, Rebecca H</creator><creator>Bregni, Marco</creator><creator>Marktel, Sarah</creator><creator>Valsecchi, Maria Grazia</creator><creator>Rossi, Paolo</creator><creator>Ciceri, Fabio</creator><creator>Miniero, Roberto</creator><creator>Bordignon, Claudio</creator><creator>Roncarolo, Maria-Grazia</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20090129</creationdate><title>Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency</title><author>Aiuti, Alessandro ; Cattaneo, Federica ; Galimberti, Stefania ; Benninghoff, Ulrike ; Cassani, Barbara ; Callegaro, Luciano ; Scaramuzza, Samantha ; Andolfi, Grazia ; Mirolo, Massimiliano ; Brigida, Immacolata ; Tabucchi, Antonella ; Carlucci, Filippo ; Eibl, Martha ; Aker, Memet ; Slavin, Shimon ; Al-Mousa, Hamoud ; Al Ghonaium, Abdulaziz ; Ferster, Alina ; Duppenthaler, Andrea ; Notarangelo, Luigi ; Wintergerst, Uwe ; Buckley, Rebecca H ; Bregni, Marco ; Marktel, Sarah ; Valsecchi, Maria Grazia ; Rossi, Paolo ; Ciceri, Fabio ; Miniero, Roberto ; Bordignon, Claudio ; Roncarolo, Maria-Grazia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c548t-ecf80bddcbf9ce96fe2b23019c808f4779081dfd4a25864545aca96e27f6f8ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adenosine Deaminase - deficiency</topic><topic>Adenosine Deaminase - genetics</topic><topic>Antigens, CD34 - genetics</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Bone Marrow Cells - immunology</topic><topic>Child, Preschool</topic><topic>Combined Modality Therapy</topic><topic>Ethics</topic><topic>Follow-Up Studies</topic><topic>Gene therapy</topic><topic>General aspects</topic><topic>Genetic Therapy</topic><topic>Genetic Vectors</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infant</topic><topic>Kinases</topic><topic>Ligands</topic><topic>Lymphocyte Count</topic><topic>Medical sciences</topic><topic>Metabolites</topic><topic>Patients</topic><topic>Retroviridae</topic><topic>Severe Combined Immunodeficiency - immunology</topic><topic>Severe Combined Immunodeficiency - therapy</topic><topic>Transduction, Genetic</topic><topic>Transplantation Conditioning</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aiuti, Alessandro</creatorcontrib><creatorcontrib>Cattaneo, Federica</creatorcontrib><creatorcontrib>Galimberti, Stefania</creatorcontrib><creatorcontrib>Benninghoff, Ulrike</creatorcontrib><creatorcontrib>Cassani, Barbara</creatorcontrib><creatorcontrib>Callegaro, Luciano</creatorcontrib><creatorcontrib>Scaramuzza, Samantha</creatorcontrib><creatorcontrib>Andolfi, Grazia</creatorcontrib><creatorcontrib>Mirolo, Massimiliano</creatorcontrib><creatorcontrib>Brigida, Immacolata</creatorcontrib><creatorcontrib>Tabucchi, Antonella</creatorcontrib><creatorcontrib>Carlucci, Filippo</creatorcontrib><creatorcontrib>Eibl, Martha</creatorcontrib><creatorcontrib>Aker, Memet</creatorcontrib><creatorcontrib>Slavin, Shimon</creatorcontrib><creatorcontrib>Al-Mousa, Hamoud</creatorcontrib><creatorcontrib>Al Ghonaium, Abdulaziz</creatorcontrib><creatorcontrib>Ferster, Alina</creatorcontrib><creatorcontrib>Duppenthaler, Andrea</creatorcontrib><creatorcontrib>Notarangelo, Luigi</creatorcontrib><creatorcontrib>Wintergerst, Uwe</creatorcontrib><creatorcontrib>Buckley, Rebecca H</creatorcontrib><creatorcontrib>Bregni, Marco</creatorcontrib><creatorcontrib>Marktel, Sarah</creatorcontrib><creatorcontrib>Valsecchi, Maria Grazia</creatorcontrib><creatorcontrib>Rossi, Paolo</creatorcontrib><creatorcontrib>Ciceri, Fabio</creatorcontrib><creatorcontrib>Miniero, Roberto</creatorcontrib><creatorcontrib>Bordignon, Claudio</creatorcontrib><creatorcontrib>Roncarolo, Maria-Grazia</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aiuti, Alessandro</au><au>Cattaneo, Federica</au><au>Galimberti, Stefania</au><au>Benninghoff, Ulrike</au><au>Cassani, Barbara</au><au>Callegaro, Luciano</au><au>Scaramuzza, Samantha</au><au>Andolfi, Grazia</au><au>Mirolo, Massimiliano</au><au>Brigida, Immacolata</au><au>Tabucchi, Antonella</au><au>Carlucci, Filippo</au><au>Eibl, Martha</au><au>Aker, Memet</au><au>Slavin, Shimon</au><au>Al-Mousa, Hamoud</au><au>Al Ghonaium, Abdulaziz</au><au>Ferster, Alina</au><au>Duppenthaler, Andrea</au><au>Notarangelo, Luigi</au><au>Wintergerst, Uwe</au><au>Buckley, Rebecca H</au><au>Bregni, Marco</au><au>Marktel, Sarah</au><au>Valsecchi, Maria Grazia</au><au>Rossi, Paolo</au><au>Ciceri, Fabio</au><au>Miniero, Roberto</au><au>Bordignon, Claudio</au><au>Roncarolo, Maria-Grazia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2009-01-29</date><risdate>2009</risdate><volume>360</volume><issue>5</issue><spage>447</spage><epage>458</epage><pages>447-458</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>Deficiency of adenosine deaminase (ADA) causes a form of severe combined immunodeficiency disease. This study shows that gene therapy in the form of hematopoietic stem cells transduced with a viral vector containing the human ADA gene can restore immune function in patients with this disease. Deficiency of adenosine deaminase causes a form of severe combined immunodeficiency disease. This study shows that gene therapy can restore immune function in patients with the disease. Adenosine deaminase (ADA) deficiency is a fatal autosomal recessive form of severe combined immunodeficiency (SCID), of which failure to thrive, impaired immune responses, and recurrent infections are characteristics. 1 , 2 Toxic levels of purine metabolites (adenosine and adenine deoxyribonucleotides) due to the deficiency of ADA can cause hepatic, skeletal, neurologic, and behavioral alterations 1 , 3 , 4 and sensorineural deafness. 5 A hematopoietic stem-cell transplant from an HLA-identical sibling, the treatment of choice, is available for only a minority of patients 6 – 8 ; the use of alternative donors is associated with a high risk of death or lack of engraftment. 1 , 6 Administration of polyethylene . . .</abstract><cop>Waltham, MA</cop><pub>Massachusetts Medical Society</pub><pmid>19179314</pmid><doi>10.1056/NEJMoa0805817</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2009-01, Vol.360 (5), p.447-458
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_66865046
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine
subjects Adenosine Deaminase - deficiency
Adenosine Deaminase - genetics
Antigens, CD34 - genetics
Biological and medical sciences
Bone marrow
Bone Marrow Cells - immunology
Child, Preschool
Combined Modality Therapy
Ethics
Follow-Up Studies
Gene therapy
General aspects
Genetic Therapy
Genetic Vectors
Hematopoietic Stem Cell Transplantation
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infant
Kinases
Ligands
Lymphocyte Count
Medical sciences
Metabolites
Patients
Retroviridae
Severe Combined Immunodeficiency - immunology
Severe Combined Immunodeficiency - therapy
Transduction, Genetic
Transplantation Conditioning
Transplants & implants
title Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T04%3A36%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gene%20Therapy%20for%20Immunodeficiency%20Due%20to%20Adenosine%20Deaminase%20Deficiency&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Aiuti,%20Alessandro&rft.date=2009-01-29&rft.volume=360&rft.issue=5&rft.spage=447&rft.epage=458&rft.pages=447-458&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJMoa0805817&rft_dat=%3Cproquest_cross%3E66865046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223913495&rft_id=info:pmid/19179314&rfr_iscdi=true